Breast Cancer Patient Equity Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Breast Cancer Patient Equity Act (H.R. 4779) is a legislative proposal introduced in the 118th Congress aimed at addressing disparities in breast cancer patient care. While the official summary and full text are not available, the bill's title and policy area indicate a focus on promoting equity in health outcomes for breast cancer patients. The bill was referred to the House Subcommittee on Health but ultimately failed or expired without further legislative action.
H.R. 4779 sought to promote equity in breast cancer patient care but did not advance beyond subcommittee referral and expired without passage.
- The bill is titled the Breast Cancer Patient Equity Act and falls under the health policy area.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on December 17, 2024.
- No official summary or full text is publicly available, and the bill status is recorded as failed or expired.
['Breast cancer patients potentially facing disparities in care', 'Healthcare providers and organizations focused on breast cancer treatment and equity', 'Public health agencies involved in cancer prevention and control']
['Lack of publicly available bill text and summary limits understanding of specific provisions and implementation requirements', 'Unclear funding mechanisms or enforcement authorities due to missing details', 'Potential challenges in oversight and measuring impact given absence of detailed legislative language']
The bill was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health. It did not progress further and is recorded as failed or expired. The legislative context suggests an effort to address health equity in breast cancer care, a recognized public health issue, but no further legislative activity or debate is documented.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased awareness and prioritization of breast cancer equity issues in future legislation', 'Possible influence on healthcare providers and public health programs to consider equity in breast cancer care despite lack of enacted law', 'Legislative failure may prompt advocacy groups to seek alternative policy or funding approaches']
The absence of an official summary and full bill text limits transparency and public understanding of the bill's specific goals and mechanisms. This lack of detail poses challenges for oversight and accountability. Additionally, the bill's failure to advance beyond subcommittee referral suggests limited legislative momentum or support during the 118th Congress.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.